Cleared Traditional

K142326 - HP Tissue Matrix

K142326 is the FDA 510(k) clearance for HP Tissue Matrix by Lifecell Corporation. It is a Class 2 General & Plastic Surgery device (product code FTM) cleared through the Traditional 510(k) pathway after a 125-day FDA review.

K142326 · Lifecell Corporation · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
125d
Days
Class 2
Risk

K142326 is an FDA 510(k) clearance for the HP Tissue Matrix. Classified as Mesh, Surgical (product code FTM), Class II - Special Controls.

Submitted by Lifecell Corporation (Branchburg, US). The FDA issued a Cleared decision on December 23, 2014 after a review of 125 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Lifecell Corporation devices

Submission Details

510(k) Number K142326 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 2014
Decision Date December 23, 2014
Days to Decision 125 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 115d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FTM Mesh, Surgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTM Mesh, Surgical

All 45
Devices cleared under the same product code (FTM) and FDA review panel - the closest regulatory comparables to K142326.
Gentrix Surgical Matrix, Gentrix Surgical Matrix Hiatal
K182259 · Acell, Inc. · Feb 2019
CanGaroo Neuro Envelope (small)
K182255 · Aziyo Biologics, Inc. · Nov 2018
Biodesign Diaphragmatic Hernia Graft
K171817 · Cook Biotech Incorporated · Mar 2018
PERMACOL SURGICAL IMPLANT
K120605 · Covidien, LLC · May 2012
COLLAGEN RIBBON
K120019 · Wrightmedicaltechnologyinc · Feb 2012
COLLAMEND FM IMPLANT
K082687 · C.R. Bard, Inc. · Oct 2008